Get 20% lifetime commission for referring investors to digrin.com
here.
KALA BIO, Inc. ( KALA) - Stock Earnings
KALA Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 10, 2026, midnight | — / — | — | — / — | — |
KALA Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 686000 USD | — USD |
| 2026Q1 | -1.6 million USD | — USD |
| 2026Q2 | -1.6 million USD | — USD |
| 2026Q4 Est. | — | — |
KALA Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -42.2 million USD | — USD |
| 2024 | -38.5 million USD | — USD |
| 2025 | -27.0 million USD | — USD |
| 2026 Est. | — | — |
KALA
Price: $0.19
52 week price:
Earnings Per Share: -9.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.0 million
Ebitda: -9.9 millionMarket Capitalization: 7.0 million